Wells Fargo Maintains Overweight on Ventyx Biosciences, Lowers Price Target to $11
Ventyx Biosciences Analyst Ratings
Ventyx Biosciences (VTYX) Receives a Buy From Oppenheimer
Ventyx Biosciences: A Buy Rating Backed by Promising Clinical Trials and Strong Financials
Ventyx Biosciences: A Cautious Hold Amid Intensifying Competition in Obesity Treatment Market
Ventyx Biosciences Price Target Maintained With a $6.00/Share by HC Wainwright & Co.
HC Wainwright & Co. Reiterates Neutral on Ventyx Biosciences, Maintains $6 Price Target
Ventyx Biosciences Analyst Ratings
H.C. Wainwright Maintains Ventyx Biosciences(VTYX.US) With Hold Rating, Maintains Target Price $6
Ventyx Biosciences: Hold Rating Affirmed Amid Clinical and Strategic Setbacks
LifeSci Capital Maintains Ventyx Biosciences(VTYX.US) With Buy Rating
LifeSci Capital Keeps Their Buy Rating on Ventyx Biosciences (VTYX)
Ventyx Biosciences Analyst Ratings
HC Wainwright & Co. Reiterates Neutral on Ventyx Biosciences, Maintains $6 Price Target
Ventyx Biosciences Analyst Ratings
HC Wainwright & Co. Reiterates Neutral on Ventyx Biosciences, Maintains $6 Price Target
Ventyx Biosciences (VTYX) Receives a Buy From LifeSci Capital
Stifel Nicolaus Keeps Their Hold Rating on Ventyx Biosciences (VTYX)
Analysts Offer Insights on Healthcare Companies: Quantum-Si (QSI), Savara (SVRA) and Ventyx Biosciences (VTYX)
Ventyx Biosciences (VTYX) Receives a Buy From Oppenheimer